InsiderClue
← All stocks

Turn Therapeutics Inc.

TTRX Net buying
CIK 0002023016 #3605 in the set updated 22 Sep 2026
Bought (12 mo)
$308.46K
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$308.46K
+$308.46K against sales at will

By person

8 insiders · 9 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
GOLDEN ARTHUR F
Director
$192.87K (3)
—
+$192.87K
360,602
1.21%
$1.26M
—
Chesed Abraham
Board Observer
$65.72K (1)
—
+$65.72K
1,447,268
4.86%
$5.07M
+1.0%
Chaudhary Zuraiz
See Remarks
$49.87K (5)
—
+$49.87K
12,500
0.0420%
$43.75K
—
Burnam Bradley Evan
Chief Executive Officer
—
—
—
300,000
1.01%
$1.05M
−50.0%
Dewhurst Martin William
Director
—
—
—
21,882
0.0735%
$76.59K
—
Gengos Andrew
Director
—
—
—
10,000
0.0336%
$35.00K
—
Kester Kent Edward
Director
—
—
—
10,000
0.0336%
$35.00K
—
Ghodadra Neilesh Shailesh
Chief Medical Officer
—
—
—
10,000
0.0336%
$35.00K
—

Individual transactions

9
Insider
Date
Role
Action
Shares
Price
Amount
Chaudhary Zuraiz
12 Dec 2025
See Remarks
Buy
2,500
$3.50
$8.75K
GOLDEN ARTHUR F
24 Nov 2025
Director
Buy
9,868
$3.44
$33.95K
Chaudhary Zuraiz
21 Nov 2025
See Remarks
Buy
1,000
$3.29
$3.29K
GOLDEN ARTHUR F
21 Nov 2025
Director
Buy
20,532
$2.87
$58.93K
Chaudhary Zuraiz
20 Nov 2025
See Remarks
Buy
1,450
$2.61
$3.78K
Chaudhary Zuraiz
17 Nov 2025
See Remarks
Buy
2,500
$3.62
$9.05K
GOLDEN ARTHUR F
23 Oct 2025
Director
Buy
20,202
$4.95
$100.00K
Chaudhary Zuraiz
23 Oct 2025
See Remarks
Buy
5,050
$4.95
$25.00K
Chesed Abraham
23 Oct 2025
Board Observer
Buy indirect
14,286
$4.60
$65.72K
Show all 9 transactions →

What was left out

Form 4 filings counted 23
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 1,861,882
History held since 10 Oct 2025